市场调查报告书
商品编码
1499432
全球生育力测试设备市场:按产品、性别、购买类型和最终用途 - 预测(2024-2030)Fertility Testing Devices Market by Product (Fertility Monitors, Fertility Tracker, Imaging Devices), Gender (Men, Women), Mode Of Purchase, End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年全球生育检测设备市场规模为6.2449亿美元,2024年达6.6064亿美元,2030年达9.3724亿美元,复合年增长率为5.97%。
生育力测试设备是用于评估男性和女性生育力的专用工具和设备。这些设备在识别与不孕症相关的问题方面发挥着重要作用,使个人和夫妇能够就其怀孕和生殖健康做出明智的决定。生育力测试设备从简单的市售套件到更复杂的临床设备。性健康和生殖健康问题的普遍存在、人们对维持男女生殖健康重要性的认识不断提高,以及政府支持生殖健康教育的努力,导致不孕症检测设备的采用越来越多。然而,开发和製造先进的不孕症检测设备成本高昂,可能会限制某些用户的市场准入,技术限制可能会导致不孕症检测结果不准确。此外,对资料收集和病患隐私的担忧引发了对生育力测试设备的安全性和可靠性的质疑。然而,领先的公司正在探索开发智慧连网型设备,这些设备可以使用人工智慧和先进的资料分析来提供肥沃视窗的预测性见解,并提供先进的安全功能。研究和开发提高用户舒适度的非侵入性测试方法也可以为该行业提供新的成长途径。
主要市场统计 | |
---|---|
基准年[2023] | 6.2449亿美元 |
预计年份 [2024] | 66064万美元 |
预测年份 [2030] | 9.3724亿美元 |
复合年增长率(%) | 5.97% |
区域洞察
在以美国和加拿大为中心的美洲地区,由于医疗基础设施的发展、对不孕症问题的高度认识以及研发方面的大量投资,不孕症检测设备市场正在快速成长。最近的非侵入性检测技术专利和生育力检测设备线上零售的激增正在推动市场发展。欧洲是一个多元化的市场,拥有广泛的医疗保健系统和优惠的报销政策。德国、英国、法国等国家由于认知度高、首次怀孕年龄增加以及政府对不孕症治疗的支持,在生育检测设备的消费方面处于领先地位。此外,有关医疗设备开发、效能、资料隐私和效率的严格标准和法规为生殖技术创新创造了高度标准化的环境。中东地区对不孕症检测设备的需求正在增加,这主要是由于医疗保健支出增加、与生活方式相关的不孕症盛行率增加以及对不孕不育治疗的接受度提高。由于生殖健康意识不断提高以及政府支持生殖健康教育的倡议,亚太地区生育检测设备市场正在迅速扩大。在中国,政府放宽独生子女政策也为不孕症检测设备开拓了市场。日本面临独特的挑战:出生率下降和人口老化。因此,强大的医疗保健系统和不孕症诊断技术进步的结合增加了对不孕症检测设备的需求。在印度,由于不孕率上升、意识提高和医疗设施改善,对不孕症检测设备的需求正在迅速增加。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在生育力测试设备市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对生育力测试设备市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在生育测试设备市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[194 Pages Report] The Fertility Testing Devices Market size was estimated at USD 624.49 million in 2023 and expected to reach USD 660.64 million in 2024, at a CAGR 5.97% to reach USD 937.24 million by 2030.
Fertility testing devices are specialized tools and instruments used to assess fertility in both men and women. These devices play a critical role in identifying fertility-related issues, enabling individuals and couples to make informed decisions about conception and reproductive health. The range of fertility testing devices varies from simple over-the-counter kits to more advanced, clinic-based equipment. The prevalence of sexual and reproductive health issues, increasing recognition of the importance of maintaining reproductive health among women and men, and government initiatives supporting reproductive health education have escalated the adoption of fertility testing devices. However, the development and manufacturing of advanced fertility testing devices can be expensive, potentially limiting market access for some users, and technical limitations can lead to inaccuracies in fertility testing results. Additionally, concerns related to data collection and patient privacy raise issues regarding the safety and reliability of fertility testing devices. However, key players are exploring the development of smart, connected devices that can offer predictive insights into fertility windows using AI and advanced data analytics and also provide advanced security features. Researching and developing non-invasive testing methods that increase user comfort can also provide new avenues of growth for the industry.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 624.49 million |
Estimated Year [2024] | USD 660.64 million |
Forecast Year [2030] | USD 937.24 million |
CAGR (%) | 5.97% |
Regional Insights
In the Americas region, particularly the U.S. and Canada, the fertility testing devices market is burgeoning, attributed to advanced healthcare infrastructure, high awareness levels about fertility issues, and significant investments in research and development. Recent patents in non-invasive testing technologies and a surge in online retailing of fertility testing devices are propelling the market forward. Europe exhibits a diverse market with extensive healthcare systems and favorable reimbursement policies. Countries such as Germany, the U.K., and France lead in fertility testing device consumption due to high awareness, increasing age of first-time pregnancies, and governmental support for fertility treatments. Furthermore, the presence of stringent standards and regulations regarding the development, performance, data privacy, and efficiency of medical devices, including fertility testing devices, has created a highly standardized landscape for innovations in reproductive health technologies. The Middle East shows a need for fertility testing devices, largely due to rising healthcare expenditure, increasing prevalence of lifestyle-induced infertility, and growing acceptance of fertility treatments. APAC's fertility testing devices market is expanding rapidly due to increasing awareness about reproductive health and government initiatives supporting reproductive health education. In China, the government's relaxation of the one-child policy has also opened up the market for fertility testing devices. Japan faces a unique challenge with a declining birth rate and an aging population. This has led to a heightened demand for fertility testing devices, coupled with a strong healthcare system and technological advancements in fertility diagnostics. India is witnessing a surge in the need for fertility testing devices due to rising infertility rates, growing awareness, and improving healthcare facilities.
Market Insights
The market dynamics represent an ever-changing landscape of the Fertility Testing Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Fertility Testing Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Fertility Testing Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
India-based Start-Up Launches At-Home Fertility Test
In a significant advancement for women's reproductive health, Arva Health, has launched an at-home fertility test designed to empower women by offering detailed insights into their hormone levels. Aimed particularly at Indian women battling conditions such as polycystic ovary syndrome (PCOS) and thyroid issues, this cost-effective solution promises to measure up to twelve critical hormone levels tied to fertility. [Published On: 2023-12-15]
Fertilly Launches Fertility Kits with Microsampling Devices in Europe
Trajan Scientific and Medical is revolutionizing the path to parenthood in Europe by partnering with the German start-up Fertilly to launch the continent's inaugural at-home fertility test kits, employing CE-IVD registered Mitra devices equipped with cutting-edge VAMS technology. This innovative partnership ensures the kits are medically certified, offering potential parents a convenient, private means to assess their reproductive health from the comfort of their home. [Published On: 2023-08-15]
Fertility Wellness Brand OVUM Launches Fully Recyclable Pregnancy Test
OVUM, a pioneering fertility wellness brand, has announced the global launch of the first fully recyclable pregnancy test, setting a new environmental and cost-friendly benchmark in fertility testing. Despite the launch of a new product line, OVUM showcases its commitment to sustainability by achieving a 'plastic negative' certification from rePurpose Global, pledging to eliminate double the amount of plastic it generates. [Published On: 2023-03-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Fertility Testing Devices Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Fertility Testing Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuMed, AccuQuik, bioZhena Corporation, Church & Dwight Co., Inc., Clinical Guard, Daysy Fertility Monitor, Fairhaven Health, Femometer, Geratherm Medical AG, Get Stix, Inc., Kegg by Lady Technologies, Inc., Mira Care, Piramal Health, Proov, Samplytics Technologies Private Limited, Swiss Precision Diagnostics GmbH, TaiDoc Technology Corporation, Tempdrop, The Boots Company PLC, UEBE Medical GmbH, Valley Electronics AG, viO HealthTech Limited, and Wondfo Biotech.
Market Segmentation & Coverage